"Designing Growth Strategies is in our DNA"

Influenza Vaccine Market Size, Share & COVID-19 Impact Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI101896

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launch
    2. Technological Advancements in the Market
    3. Prevalence of Disease Indication- For Key Countries, 2019
    4. Impact of COVID-19 on Influenza Vaccine Market
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Influenza Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    4. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Inactivated
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast  – By Valency
      1. Quadrivalent
      2. Trivalent
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Influenza Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Inactivated
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast  – By Valency
      1. Quadrivalent
      2. Trivalent
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Influenza Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Inactivated
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast  – By Valency
      1. Quadrivalent
      2. Trivalent
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Influenza Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Inactivated
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast  – By Valency
      1. Quadrivalent
      2. Trivalent
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Influenza Vaccine Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Type
      1. Inactivated
      2. Live Attenuated
    3. Market Analysis, Insights and Forecast  – By Valency
      1. Quadrivalent
      2. Trivalent
    4. Market Analysis, Insights and Forecast  – By Age Group
      1. Pediatric
      2. Adults
    5. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Products, SWOT, Recent Developments, Strategies, Financials (Based on Availability))
      1. Sanofi
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. CSL Limited
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. GlaxoSmithKline plc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. AstraZeneca
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. BioDiem
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Emergent BioSolutions Inc.
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Sinovac Biotech Ltd
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Other Prominent Players
        1. Overview,
        2. Products,
        3. SWOT,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations

List of Tables

Table 1:  Global Influenza Vaccine Market Revenue (USD Billion) Forecast, by Type, 2016-2027

Table 2:  Global Influenza Vaccine Market Revenue (USD Billion) Forecast, by Valency, 2016-2027

Table 3:  Global Influenza Vaccine Market Revenue (USD Billion) Forecast, by Age Group, 2016-2027

Table 4:  Global Influenza Vaccine Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 5:  Global Influenza Vaccine Market Revenue (USD Billion) Forecast, by Region, 2016-2027

Table 6:  North America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Type, 2016-2027

Table 7:  North America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Valency, 2016-2027

Table 8:  North America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Age Group, 2016-2027

Table 9:  North America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 10:  North America Influenza Vaccine Market Revenue (USD Billion) Forecast, By Country, 2016-2027

Table 11:  Europe Influenza Vaccine Market Revenue (USD Billion) Forecast, by Type, 2016-2027

Table 12:  Europe Influenza Vaccine Market Revenue (USD Billion) Forecast, by Valency, 2016-2027

Table 13:  Europe Influenza Vaccine Market Revenue (USD Billion) Forecast, by Age Group, 2016-2027

Table 14:  Europe Influenza Vaccine Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 15:  Europe Influenza Vaccine Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 16:  Asia Pacific Influenza Vaccine Market Revenue (USD Billion) Forecast, by Type, 2016-2027

Table 17:  Asia Pacific Influenza Vaccine Market Revenue (USD Billion) Forecast, by Valency, 2016-2027

Table 18:  Asia Pacific Influenza Vaccine Market Revenue (USD Billion) Forecast, by Age Group, 2016-2027

Table 19:  Asia Pacific Influenza Vaccine Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 20:  Asia Pacific Influenza Vaccine Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 21:  Latin America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Type, 2016-2027

Table 22:  Latin America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Valency, 2016-2027

Table 23:  Latin America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Age Group, 2016-2027

Table 24:  Latin America Influenza Vaccine Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 25:  Latin America Influenza Vaccine Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

Table 26:  Middle East & Africa Influenza Vaccine Market Revenue (USD Billion) Forecast, by Type, 2016-2027

Table 27:  Middle East & Africa Influenza Vaccine Market Revenue (USD Billion) Forecast, by Valency, 2016-2027

Table 28:  Middle East & Africa Influenza Vaccine Market Revenue (USD Billion) Forecast, by Age Group, 2016-2027

Table 29:  Middle East & Africa Influenza Vaccine Market Revenue (USD Billion) Forecast, by Distribution Channel, 2016-2027

Table 30:  Middle East & Africa Influenza Vaccine Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2016-2027

List of Figures

Figure 1:  Global Influenza Vaccine Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027

Figure 2:  Global Influenza Vaccine Market Value Share (%), by Type, 2019 & 2027

Figure 3:  Global Influenza Vaccine Market Forecast (USD Billion), by Inactivated, 2016-2027

Figure 4:  Global Influenza Vaccine Market Forecast (USD Billion), by Live Attenuated, 2016-2027

Figure 5:  Global Influenza Vaccine Market Value Share (%), by Valency, 2019 & 2027

Figure 6:  Global Influenza Vaccine Market Forecast (USD Billion), by Quadrivalent, 2016-2027

Figure 7:  Global Influenza Vaccine Market Forecast (USD Billion), by Trivalent, 2016-2027

Figure 8:  Global Influenza Vaccine Market Value Share (%), by Age Group, 2019 & 2027

Figure 9:  Global Influenza Vaccine Market Forecast (USD Billion), by Pediatric, 2016-2027

Figure 10:  Global Influenza Vaccine Market Forecast (USD Billion), by Adults, 2016-2027

Figure 11:  Global Influenza Vaccine Market Value Share (%), by Distribution Channel, 2019 & 2027

Figure 12:  Global Influenza Vaccine Market Forecast (USD Billion), by Hospital & Retail Pharmacies, 2016-2027

Figure 13:  Global Influenza Vaccine Market Forecast (USD Billion), by Government Suppliers, 2016-2027

Figure 14:  Global Influenza Vaccine Market Forecast (USD Billion), by Others, 2016-2027

Figure 15:  Global Influenza Vaccine Market Value (USD Billion), by Region, 2019 & 2027

Figure 16:  North America Influenza Vaccine Market Value (USD Billion), by Type, 2019 & 2027

Figure 17:  North America Influenza Vaccine Market Value Share (%), by Type, 2019

Figure 18:  North America Influenza Vaccine Market Value (USD Billion), by Valency, 2019 & 2027

Figure 19:  North America Influenza Vaccine Market Value Share (%), by Valency, 2019

Figure 20:  North America Influenza Vaccine Market Value (USD Billion), by Age Group, 2019 & 2027

Figure 21:  North America Influenza Vaccine Market Value Share (%), by Age Group, 2019

Figure 22:  North America Influenza Vaccine Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 23:  North America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 24:  North America Influenza Vaccine Market Value (USD Billion), By Country, 2019 & 2027

Figure 25:  North America Influenza Vaccine Market Value Share (%), By Country, 2019

Figure 26:  Europe Influenza Vaccine Market Value (USD Billion), by Type, 2019 & 2027

Figure 27:  Europe Influenza Vaccine Market Value Share (%), by Type, 2019

Figure 28:  Europe Influenza Vaccine Market Value (USD Billion), by Valency, 2019 & 2027

Figure 29:  Europe Influenza Vaccine Market Value Share (%), by Valency, 2019

Figure 30:  Europe Influenza Vaccine Market Value (USD Billion), by Age Group, 2019 & 2027

Figure 31:  Europe Influenza Vaccine Market Value Share (%), by Age Group, 2019

Figure 32:  Europe Influenza Vaccine Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 33:  Europe Influenza Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 34:  Europe Influenza Vaccine Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 35:  Europe Influenza Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 36:  Asia Pacific Influenza Vaccine Market Value (USD Billion), by Type, 2019 & 2027

Figure 37:  Asia Pacific Influenza Vaccine Market Value Share (%), by Type, 2019

Figure 38:  Asia Pacific Influenza Vaccine Market Value (USD Billion), by Valency, 2019 & 2027

Figure 39:  Asia Pacific Influenza Vaccine Market Value Share (%), by Valency, 2019

Figure 40:  Asia Pacific Influenza Vaccine Market Value (USD Billion), by Age Group, 2019 & 2027

Figure 41:  Asia Pacific Influenza Vaccine Market Value Share (%), by Age Group, 2019

Figure 42:  Asia Pacific Influenza Vaccine Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 43:  Asia Pacific Influenza Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 44:  Asia Pacific Influenza Vaccine Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 45:  Asia Pacific Influenza Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 46:  Latin America Influenza Vaccine Market Value (USD Billion), by Type, 2019 & 2027

Figure 47:  Latin America Influenza Vaccine Market Value Share (%), by Type, 2019

Figure 48:  Latin America Influenza Vaccine Market Value (USD Billion), by Valency, 2019 & 2027

Figure 49:  Latin America Influenza Vaccine Market Value Share (%), by Valency, 2019

Figure 50:  Latin America Influenza Vaccine Market Value (USD Billion), by Age Group, 2019 & 2027

Figure 51:  Latin America Influenza Vaccine Market Value Share (%), by Age Group, 2019

Figure 52:  Latin America Influenza Vaccine Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 53:  Latin America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 54:  Latin America Influenza Vaccine Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 55:  Latin America Influenza Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 56:  Middle East & Africa Influenza Vaccine Market Value (USD Billion), by Type, 2019 & 2027

Figure 57:  Middle East & Africa Influenza Vaccine Market Value Share (%), by Type, 2019

Figure 58:  Middle East & Africa Influenza Vaccine Market Value (USD Billion), by Valency, 2019 & 2027

Figure 59:  Middle East & Africa Influenza Vaccine Market Value Share (%), by Valency, 2019

Figure 60:  Middle East & Africa Influenza Vaccine Market Value (USD Billion), by Age Group, 2019 & 2027

Figure 61:  Middle East & Africa Influenza Vaccine Market Value Share (%), by Age Group, 2019

Figure 62:  Middle East & Africa Influenza Vaccine Market Value (USD Billion), by Distribution Channel, 2019 & 2027

Figure 63:  Middle East & Africa Influenza Vaccine Market Value Share (%), by Distribution Channel, 2019

Figure 64:  Middle East & Africa Influenza Vaccine Market Value (USD Billion), By Country/ Sub-region, 2019 & 2027

Figure 65:  Middle East & Africa Influenza Vaccine Market Value Share (%), By Country/ Sub-region, 2019

Figure 66:  Global Influenza Vaccine Market Share (%), By Company, 2019

 class=
  • Sep, 2020
  • 2019
  • 2016-2018
  • 144

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X